Synthesis method and application of alfasalone

A six-step synthesis method using cortisone acetate addresses the challenges of impurity removal and cost in alfaxalone production, achieving high yield and purity suitable for anesthetic drugs.

CN119060113APending Publication Date: 2024-12-03HUBEI LONGXIANG PHARMA TECH CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311827435.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-12-28
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The synthesis of alfaxalone is challenging due to the difficulty in removing isomeric impurities, high production costs, and low yields in existing methods, making it difficult to meet the demands of industrial-scale production and ensure drug quality.

Method used

A six-step synthesis method using cortisone acetate as a starting material, involving hydrolysis, hydrogenation, dehydroxylation, reduction, carbonyl protection, and carbonyl deprotection, with specific reaction conditions and reagents to achieve high purity and yield.

Benefits of technology

The method achieves high feasibility, low production costs, and high yields (>27%), effectively removing isomeric impurities, resulting in high-purity alfaxalone suitable for anesthetic drug preparations.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004635511320000011
    Figure BDA0004635511320000011
  • Figure BDA0004635511320000012
    Figure BDA0004635511320000012
  • Figure BDA0004635511320000021
    Figure BDA0004635511320000021
Patent Text Reader

Abstract

The invention relates to a synthetic method and application of alfasalone, and the synthetic method specifically comprises the following steps: taking cortisone acetate as an initial reactant, and carrying out six-step reaction of hydrolysis, hydrogenation, hydroxyl removal, carbonyl reduction, carbonyl protection and carbonyl deprotection to obtain the alfasalone. The synthesis method of alfasalone provided by the invention is simple in route, cheap in raw materials, high in product quality and yield, and suitable for industrial mass production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of chemical drug synthesis, and specifically relates to a synthesis method and application of alfaxalone. Background Art

[0002] Alfaxalone was developed and marketed by GSK in the 1970s and 1980s. It is a steroidal anesthetic and a GABAAR agonist. In the central nervous system, γ-aminobutyric acid (GABA) receptors exist in two forms: GABAA receptors (GABAAR) and GABAB receptors (GABABR). GABAAR plays an important role in the brain's regulation of memory, consciousness and sleep. Alfaxalone, as a GABAAR agonist, has sedative, anesthetic, anticonvulsant and neuroprotective effects. The drug has the characteristics of rapid onset, rapid recovery and relatively safe.

[0003] Alfaxalone has no accumulation when administered repeatedly, has improved safety compared to propofol, is twice as effective as the industry-leading propofol in sedation and anesthesia, causes less drop in blood pressure than propofol, and has a neuroprotective effect on the fetal and adult brain at normal anesthetic doses.

[0004]

[0005] Since the synthesis of alfaxalone involves the construction of two chiral centers, it is difficult to remove the isomeric impurities produced during the synthesis process. A high content of isomeric impurities may lead to reduced drug efficacy and the occurrence of adverse reactions. At the same time, there are few reported synthetic routes for alfaxalone, as follows:

[0006] Route 1:

[0007]

[0008] Barbora et al. (Barbora Slavíkov, et al. Allopregnanolone and Pregnanolone Analogues Modified in the C Ring: Synthesis and Activity. Journal of Medicinal Chemistry, 2013, 56 (6), 2323-2336) used 11-α-progesterone as the starting material, and obtained an intermediate with α-hydrogen at position 5 through oxidation, esterification, hydrogenation and hydrolysis, and then obtained alfaxalone with α-hydroxyl at position 3 through sulfonylation and hydrolysis. This route is lengthy, and the yields of esterification, sulfonylation and hydrolysis reactions are low, only 10-20%, resulting in high production costs. At the same time, the starting material is expensive and difficult to purchase.

[0009] Route 2:

[0010] At present, the patent CN112384525A on the synthesis of alfaxalone uses 11-α-progesterone as the starting material, and only undergoes four chemical reactions, namely hydrogenation, oxidation, reduction, and silane protection, to prepare alfaxalone. Among them, the intermediate obtained by the first step of hydrogenation reaction contains 3-5% of the 3-position β-hydrogen isomer, and the yield is only 50-60%. The yield of the second step of oxidation reaction is also only 40-50%. After the fourth step of silane protection reaction, the reduced isomer impurity silane protection is removed by column purification, but the hydrogenated isomer impurity cannot be effectively removed.

[0011]

[0012] Therefore, in order to effectively reduce the production cost of alfaxalone and ensure the quality of the product, it is necessary to design a synthesis route of alfaxalone with low cost, high yield, mild conditions and suitable for large-scale industrial production. Summary of the invention

[0013] The present invention aims to solve the problems in the prior art and provide a synthesis method and application of alfaxalone. The method has the following advantages: simple route, cheap raw materials, low synthesis cost, high product yield, mild reaction conditions, suitable for industrial scale-up production, and can meet the large demand of the API market.

[0014] The present invention provides a method for synthesizing alfaxalone. Cortisone acetate is used as a starting material, and the method is subjected to six steps of hydrolysis, hydrogenation, dehydroxylation (hydroxyl removal), reduction (carbonyl reduction), carbonyl protection, and carbonyl deprotection. The specific route is as follows:

[0015]

[0016] The specific synthesis steps are as follows:

[0017] (1) Hydrolysis reaction: cortisone acetate is added to a reaction solvent, and sodium hydroxide solution is added at a certain temperature to carry out the reaction. During the reaction, the progress of the reaction is monitored by TLC. After the reaction is complete, hydrochloric acid solution is added to terminate the reaction. The organic phase is concentrated, crystallized by adding water, and dried to obtain intermediate 1.

[0018] Preferably, the amount of sodium hydroxide added in step (1) is 1.1 to 1.5 times the molar amount of cortisone acetate; the reaction solvent is one or more of methanol, ethanol, n-propanol, isopropanol, n-butanol, sec-butanol, and tert-butanol; the volume of the reaction solvent added is 5 to 15 times the mass of cortisone acetate; and the reaction temperature is 0 to 10°C.

[0019] More preferably, the reaction solvent in step (1) is methanol.

[0020] (2) Hydrogenation reaction: intermediate 1, palladium carbon and an amine solvent are added to a reaction solvent, and a hydrogenation reaction is carried out at a certain temperature and under normal pressure. During the reaction, the progress of the reaction is monitored by TLC. After the reaction is complete, the organic phase is filtered, concentrated, recrystallized and dried to obtain intermediate 2.

[0021] Preferably, the amount of palladium carbon added in step (2) is 0.03 to 0.10 times the mass of intermediate 1; the amine solvent is selected from triethylamine, diethylamine, ethylenediamine, N,N-diisopropylethylamine; the volume of the amine solvent added is 0.1 to 2.0 times the mass of intermediate 1; the reaction solvent is one or more of dichloromethane, chloroform, tetrahydrofuran, 2-methyltetrahydrofuran, toluene, o-xylene, p-xylene, and m-xylene; the volume of the reaction solvent added is 10 to 30 times the mass of intermediate 1; the reaction temperature is 20 to 50°C; the recrystallization solvent is selected from acetone, acetonitrile, methanol, ethanol, and isopropanol; the volume of the recrystallization solvent added is 3 to 10 times the mass of intermediate 1.

[0022] More preferably, in step (2), the amine solvent is triethylamine; the reaction solvent is toluene; and the recrystallization solvent is acetonitrile.

[0023] (3) Dehydroxylation reaction: intermediate 2 is added to a reaction solvent, trimethylsilyl chloride and iodide salt are added in sequence at a certain temperature, and the reaction is carried out at a certain temperature. During the reaction, the progress of the reaction is monitored by TLC. After the reaction is complete, sodium thiosulfate solution is added to terminate the reaction. The organic phase is concentrated, recrystallized and dried to obtain intermediate 3.

[0024] Preferably, in step (3), the amount of trimethylsilyl chloride added is 2.0 to 10.0 times the molar amount of intermediate 2; the iodide salt is selected from sodium iodide, potassium iodide, copper iodide, zinc iodide, calcium iodide, and magnesium iodide; the amount of iodide salt added is 0.1 to 0.5 times the molar amount of intermediate 2; the reaction solvent is one or more of dichloromethane, chloroform, tetrahydrofuran, 2-methyltetrahydrofuran, and acetonitrile; the volume of the reaction solvent added is 5 to 10 times the mass of intermediate 2; the reaction temperature is 0 to 10°C; the recrystallization solvent is selected from acetone, ethyl acetate, and methanol; the volume of the recrystallization solvent added is 3 to 10 times the mass of intermediate 2.

[0025] More preferably, in step (3), the reaction solvent is dichloromethane, and the recrystallization solvent is acetone.

[0026] (4) Reduction reaction: intermediate 3 is added to a reaction solvent, diisopine campheyl chloroborane is added at a certain temperature, and the reaction is carried out at a certain temperature. During the reaction, the progress of the reaction is detected by TLC. After the reaction is complete, methanol is added to terminate the reaction. The organic phase is washed with hydrochloric acid solution, sodium bicarbonate solution and water, and then concentrated, recrystallized and dried to obtain intermediate 4.

[0027] Preferably, in step (4), the added volume of diisopine campheyl chloroborane is 2 to 6 times the mass of intermediate 3; the reaction solvent is one or more of dichloromethane, chloroform, tetrahydrofuran, 2-methyltetrahydrofuran, and methyl tert-butyl ether; the added volume of the reaction solvent is 5 to 20 times the mass of intermediate 3; the reaction temperature is 0 to 10°C; the recrystallization solvent is selected from acetone, ethyl acetate, acetonitrile, and isopropanol, and the added volume of the recrystallization solvent is 3 to 20 times the mass of intermediate 3.

[0028] More preferably, the reaction solvent in step (4) is dichloromethane; and the recrystallization solvent is acetone.

[0029] (5) Carbonyl protection reaction: Intermediate 4, 1,3-propylene glycol and N-bromosuccinimide are added to triethyl orthoformate and reacted at a certain temperature. The progress of the reaction is monitored by TLC. After the reaction is complete, saturated sodium bicarbonate solution and ethyl acetate are added. The organic phase is washed with water, concentrated, recrystallized and dried to obtain intermediate 5.

[0030] Preferably, in step (5), the amount of 1,3-propylene glycol added is 2.0 to 5.0 times the molar amount of intermediate 4; the amount of N-bromosuccinimide added is 0.01 to 0.05 times the molar amount of intermediate 4; the volume of triethyl orthoformate added is 5 to 10 times the mass of intermediate 4; the reaction temperature is 20 to 30° C.; the recrystallization solvent is selected from methanol, ethanol, and isopropanol; and the volume of the recrystallization solvent added is 3 to 20 times the mass of intermediate 4.

[0031] More preferably, the recrystallization solvent in step (5) is ethanol.

[0032] (6) Carbonyl deprotection reaction: intermediate 5 and bis(acetonitrile palladium chloride) are added to a reaction solvent, and a deprotection reaction is carried out at a certain temperature. The progress of the reaction is monitored by TLC. After the reaction is complete, the organic phase is filtered, and a crystallization solvent is added after concentration, and then dried to obtain alfaxalone.

[0033] Preferably, the amount of bisacetonitrile palladium chloride added in step (6) is 0.05 to 0.1 times the molar amount of intermediate 5; the reaction solvent is one or more of acetone, butanone, cyclopentanone, and methyl isobutyl ketone; the volume of the reaction solvent added is 10 to 20 times the mass of intermediate 5; the reaction temperature is 20 to 30° C.; the crystallization solvent is selected from methanol, ethanol, isopropanol, and acetonitrile; the volume of the crystallization solvent added is 1 to 10 times the mass of intermediate 5.

[0034] More preferably, in step (6), the reaction solvent is acetone; and the crystallization solvent is acetonitrile.

[0035] The alfaxalone prepared by the alfaxalone synthesis method is used in the preparation of anesthetic drug preparations for humans and animals.

[0036] Beneficial effects:

[0037] 1. The present invention provides a novel synthesis method of alfaxalone, which has high feasibility and strong operability, can be synthesized under relatively mild conditions, does not require high temperature or ultra-low temperature, has low requirements on equipment, and is easy to industrialize.

[0038] 2. The synthesis method of alfaxalone provided by the present invention has a simple route, the starting materials and various reagents used in the synthesis are relatively cheap, the total yield is high (>27%), and the production cost of preparing alfaxalone is much lower than the synthesis route in the prior art.

[0039] 3. The present invention provides a novel method for synthesizing alfaxalone, which can effectively remove isomeric impurities through carbonyl protection and recrystallization, and can obtain alfaxalone with high purity (>99.5%) without column purification, and isomeric impurities are not detected. The prepared alfaxalone provides high-quality raw materials for the production of anesthetic drug preparations. BRIEF DESCRIPTION OF THE DRAWINGS

[0040] Figure 1 HPLC chart of alfaxalone prepared in Example 1 of the present invention;

[0041] Figure 2 HPLC chart of alfaxalone prepared in Comparative Example 1 of the present invention (25.940min, 26.513min, 28.790min are hydrogenated isomer impurities, reduced isomer impurities, and hydrogenated reduced isomer impurities, respectively);

[0042] Figure 3 The H NMR spectrum of alfaxalone prepared in Example 1 of the present invention;

[0043] Figure 4 The NMR carbon spectrum of alfaxalone prepared in Example 1 of the present invention. DETAILED DESCRIPTION

[0044] The above contents will be further described in detail below through specific implementation methods in the form of embodiments. However, this should not be understood as the scope of the above subject matter being limited to the following embodiments. All technologies realized based on the contents of the present invention are within the scope.

[0045] Example 1

[0046] (1) Methanol (5.0V relative to cortisone acetate, mass volume ratio is 1g:5ml, V in the following examples are all mass volume ratios) was added to a reaction flask, cortisone acetate (1.0eq, eq in the following examples are all molar ratios) was added, and then stirred and cooled to 0-10°C, and sodium hydroxide (1.2eq) was added in batches. After the addition was completed, the reaction was carried out at a temperature of 0-10°C. The progress of the reaction was monitored by thin layer chromatography (TLC) during the reaction. After the reaction was completed, 1M hydrochloric acid solution was added to terminate the reaction. The organic phase was concentrated to a residual volume of about 2 times (relative to 2.0V of cortisone acetate), purified water (10.0V) was added for crystallization, filtered, and dried to obtain intermediate 1 with an HPLC purity of 98% and a molar yield of 95%.

[0047] (2) Toluene (20.0V) was added to the reaction flask, followed by the addition of intermediate 1 (1.0eq), palladium carbon (0.07w / w relative to intermediate 1, mass ratio of 1g:1g, w / w in the following examples are all mass ratios) and triethylamine (0.3V), followed by nitrogen replacement 3 times and hydrogen replacement 3 times, and the reaction was carried out at a temperature of 40-50°C. During the reaction, the progress of the reaction was monitored by thin layer chromatography (TLC). After the reaction was complete, the mixture was filtered, the filter cake was rinsed with an appropriate amount of toluene, the organic phase was concentrated to no fraction, acetonitrile (5.0V) was added for recrystallization, filtration and drying to obtain intermediate 2 with an HPLC purity of 98% and a molar yield of 65%.

[0048] (3) Under nitrogen protection, dichloromethane (10.0 V) was added to the reaction flask, and intermediate 2 (1.0 eq) was added. The mixture was stirred and cooled to 0-10° C. trimethylsilyl chloride (4.0 eq) and sodium iodide (0.1 eq) were added in sequence. After the addition, the reaction was carried out at a temperature of 0-10° C. The progress of the reaction was monitored by thin layer chromatography (TLC). After the reaction was complete, a saturated sodium thiosulfate solution was added to terminate the reaction. The organic phase was concentrated to no fraction, acetone (10.0 V) was added for recrystallization, filtration and drying to obtain intermediate 3 with an HPLC purity of 95% and a molar yield of 80%.

[0049] (4) Under nitrogen protection, tetrahydrofuran (10.0 V) was added to the reaction flask, and intermediate 3 (1.0 eq) was added. The mixture was stirred and cooled to 0-10° C., and diisopine campheyl chloroborane (3.0 V) was added dropwise. After the addition was completed, the reaction was carried out at a temperature of 0-10° C. The progress of the reaction was detected by thin layer chromatography (TLC). After the reaction was completed, methanol (0.5 V) was added to terminate the reaction. The organic phase was washed with 1 M hydrochloric acid solution, saturated sodium bicarbonate solution, and water, respectively, and acetone (10.0 V) was added for recrystallization, filtration, and drying to obtain intermediate 4 with an HPLC purity of 92.50%, 2.41% hydrogenated isomer impurities, 3.12% reduced isomer impurities, 1.63% hydrogenated reduced isomer impurities, and a molar yield of 84%.

[0050] (5) Add triethyl orthoformate (10.0 V) to the reaction flask, and then add intermediate 4 (1.0 eq), 1,3-propylene glycol (3.0 eq), and N-bromosuccinimide (0.02 eq) in sequence. The reaction is carried out at a temperature of 20 to 30° C. During the reaction, the progress of the reaction is detected by thin layer chromatography (TLC). After the reaction is completed, add a mixed solvent of ethyl acetate (10.0 V) and saturated sodium bicarbonate solution (5.0 V). After separation, the organic phase is washed with water and concentrated to no fraction. Ethanol (10.0 V) is added for recrystallization, filtration, and drying to obtain intermediate 5 with an HPLC purity of 99.51% and a molar yield of 77%.

[0051] (6) Under nitrogen protection, acetone (10.0 V) was added to the reaction bottle, followed by the addition of intermediate 5 (1.0 eq) and bisacetonitrile palladium chloride (0.05 eq), and the reaction was carried out at a temperature of 20 to 30° C. During the reaction, the progress of the reaction was detected by thin layer chromatography (TLC). After the reaction was completed, the organic phase was filtered and concentrated to no fraction. Acetonitrile (5.0 V) was added for crystallization, filtered, and dried to obtain alfaxalone with an HPLC purity of 99.90%, hydrogenated isomer impurities, reduced isomer impurities, and hydrogenated reduced isomer impurities all less than 0.05%, and a molar yield of 95%.

[0052] Example 2

[0053] (1) Add ethanol (5.0V) to a reaction flask, add cortisone acetate (1.0eq), stir and cool to 0-10°C, then add sodium hydroxide (1.1eq) in batches, and react at 0-10°C after the addition. During the reaction, the progress of the reaction is detected by thin layer chromatography (TLC). After the reaction is complete, 1M hydrochloric acid solution is added to terminate the reaction. The organic phase is concentrated to a residual volume of about 2 times (relative to 2.0V of cortisone acetate), and purified water (10.0V) is added for crystallization, filtered, and dried to obtain intermediate 1 with an HPLC purity of 97% and a molar yield of 92%.

[0054] (2) Add dichloromethane (15.0V) to the reaction flask, and then add intermediate 1 (1.0eq), palladium carbon (0.09w / w) and diethylamine (0.6V) in sequence, replace the mixture with nitrogen three times and hydrogen three times, and react at a temperature of 20 to 30°C. During the reaction, the reaction progress is detected by thin layer chromatography (TLC). After the reaction is complete, filter the mixture, rinse the filter cake with an appropriate amount of dichloromethane, concentrate the organic phase until there is no fraction, add acetonitrile (5.0V) for recrystallization, filter, and dry to obtain intermediate 2 with an HPLC purity of 96% and a molar yield of 60%.

[0055] (3) Under nitrogen protection, acetonitrile (10.0 V) was added to the reaction bottle, and intermediate 2 (1.0 eq) was added. The mixture was stirred and cooled to 0-10° C., trimethylsilyl chloride (6.0 eq) and zinc iodide (0.2 eq) were added in sequence, and the reaction was carried out at a temperature of 0-10° C. The progress of the reaction was monitored by thin layer chromatography (TLC). After the reaction was completed, saturated sodium thiosulfate solution was added to terminate the reaction. The organic phase was concentrated to no fraction, and ethyl acetate (5.0 V) was added for recrystallization, filtration, and drying to obtain intermediate 3 with an HPLC purity of 95% and a molar yield of 87%.

[0056] (4) Under nitrogen protection, 2-methyltetrahydrofuran (15.0V) was added to the reaction bottle, and intermediate 3 (1.0eq) was added. The mixture was stirred and cooled to 0-10°C. Diisopine campheyl chloroborane (4.0V) was added dropwise. After the addition was completed, the reaction was carried out at a temperature of 0-10°C. The progress of the reaction was detected by thin layer chromatography (TLC). After the reaction was completed, methanol (0.5V) was added to terminate the reaction. The organic phase was washed with 1M hydrochloric acid solution, saturated sodium bicarbonate solution, and water, and isopropanol (12.0V) was added for recrystallization, filtration, and drying to obtain intermediate 4 with an HPLC purity of 91.52%, 2.21% hydrogenated isomer impurities, 3.90% reduced isomer impurities, 1.81% hydrogenated reduced isomer impurities, and a molar yield of 83%.

[0057] (5) Add triethyl orthoformate (5.0 V) to the reaction flask, and then add intermediate 4 (1.0 eq), 1,3-propylene glycol (2.0 eq), and N-bromosuccinimide (0.04 eq) in sequence. The reaction is carried out at a temperature of 20 to 30 ° C. During the reaction, the progress of the reaction is detected by thin layer chromatography (TLC). After the reaction is completed, add a mixed solvent of ethyl acetate (10.0 V) and saturated sodium bicarbonate solution (5.0 V). After separation, the organic phase is washed with water and concentrated to no fraction. Methanol (10.0 V) is added for recrystallization, filtration, and drying to obtain intermediate 5 with HPLC purity of 99.43% and molar yield of 75%.

[0058] (6) Under nitrogen protection, butanone (18.0 V) was added to the reaction flask, followed by the addition of intermediate 5 (1.0 eq) and palladium chloride bisacetonitrile (0.07 eq), and the reaction was carried out at a temperature of 20 to 30° C. During the reaction, the progress of the reaction was detected by thin layer chromatography (TLC). After the reaction was completed, the organic phase was filtered and concentrated to no fraction. Isopropanol (5.0 V) was added for crystallization, filtered, and dried to obtain alfaxalone with an HPLC purity of 99.82%, hydrogenated isomer impurities, reduced isomer impurities, and hydrogenated reduced isomer impurities all less than 0.05%, and a molar yield of 96%.

[0059] Example 3

[0060] (1) Add isopropanol (15.0V) to a reaction flask, add cortisone acetate (1.0eq), stir and cool to 0-10°C, add sodium hydroxide (1.3eq) in batches, and react at 0-10°C after the addition. During the reaction, the progress of the reaction is detected by thin layer chromatography (TLC). After the reaction is complete, 1M hydrochloric acid solution is added to terminate the reaction. The organic phase is concentrated to a residual volume of about 2 times (relative to 2.0V of cortisone acetate), and purified water (10.0V) is added. Crystallization, filtration, and drying are performed to obtain intermediate 1 with an HPLC purity of 98% and a molar yield of 92%.

[0061] (2) Tetrahydrofuran (10.0 V) was added to the reaction flask, followed by the addition of intermediate 1 (1.0 eq), palladium carbon (0.07 w / w) and ethylenediamine (0.8 V), followed by nitrogen replacement 3 times and hydrogen replacement 3 times. The reaction was carried out at a temperature of 30 to 40° C. During the reaction, the progress of the reaction was detected by thin layer chromatography (TLC). After the reaction was complete, the mixture was filtered, and the filter cake was rinsed with an appropriate amount of tetrahydrofuran. The organic phase was concentrated until there was no fraction, and methanol (4.0 V) was added for recrystallization, filtration and drying to obtain intermediate 2 with an HPLC purity of 95% and a molar yield of 65%.

[0062] (3) Under nitrogen protection, tetrahydrofuran (5.0 V) was added to the reaction bottle, and intermediate 2 (1.0 eq) was added. The mixture was stirred and cooled to 0-10° C., trimethylsilyl chloride (4.0 eq) and sodium iodide (0.1 eq) were added in sequence. After the addition, the reaction was carried out at a temperature of 0-10° C. The progress of the reaction was monitored by thin layer chromatography (TLC). After the reaction was completed, a saturated sodium thiosulfate solution was added to terminate the reaction. The organic phase was concentrated to no fraction, and methanol (5.0 V) was added for recrystallization, filtration, and drying to obtain intermediate 3 with an HPLC purity of 93% and a molar yield of 78%.

[0063] (4) Under nitrogen protection, dichloromethane (20.0V) was added to the reaction flask, and intermediate 3 (1.0eq) was added. The mixture was stirred and cooled to 0-10°C. Diisopine campheyl chloroborane (3.0V) was added dropwise. After the addition, the reaction was carried out at a temperature of 0-10°C. The progress of the reaction was detected by thin layer chromatography (TLC). After the reaction was completed, methanol (0.5V) was added to terminate the reaction. The organic phase was washed with 1M hydrochloric acid solution, saturated sodium bicarbonate solution, and water, respectively, and ethyl acetate (15.0V) was added for recrystallization, filtration, and drying to obtain intermediate 4 with an HPLC purity of 92.15%, 2.21% hydrogenated isomer impurities, 3.53% reduced isomer impurities, 1.93% hydrogenated reduced isomer impurities, and a molar yield of 85%.

[0064] (5) Add triethyl orthoformate (9.0 V) to the reaction flask, and then add intermediate 4 (1.0 eq), 1,3-propylene glycol (5.0 eq), and N-bromosuccinimide (0.01 eq) in sequence. The reaction is carried out at a temperature of 20 to 30° C. During the reaction, the progress of the reaction is detected by thin layer chromatography (TLC). After the reaction is completed, add a mixed solvent of ethyl acetate (10.0 V) and saturated sodium bicarbonate solution (5.0 V). After separation, the organic phase is washed with water and concentrated to no fraction. Isopropanol (10.0 V) is added for recrystallization, filtration, and drying to obtain intermediate 5 with an HPLC purity of 99.45% and a molar yield of 78%.

[0065] (6) Under nitrogen protection, methyl isobutyl ketone (15.0 V) was added to the reaction bottle, followed by the intermediate 5 (1.0 eq) and bisacetonitrile palladium chloride (0.06 eq), and the reaction was carried out at a temperature of 20 to 30° C. During the reaction, the progress of the reaction was detected by thin layer chromatography (TLC). After the reaction was completed, the organic phase was filtered and concentrated to no fraction. Ethanol (5.0 V) was added for crystallization, filtered, and dried to obtain alfaxalone with an HPLC purity of 99.88%, hydrogenated isomer impurities, reduced isomer impurities, and hydrogenated reduced isomer impurities all less than 0.05%, and a molar yield of 92%.

[0066] Example 4

[0067] (1) n-propanol (10.0V) was added to a reaction flask, followed by the addition of cortisone acetate (1.0eq), followed by stirring and cooling to 0-10°C, and sodium hydroxide (1.3eq) was added in batches. After the addition was completed, the reaction was carried out at a temperature of 0-10°C. During the reaction, the progress of the reaction was monitored by thin layer chromatography (TLC). After the reaction was completed, 1M hydrochloric acid solution was added to terminate the reaction. The organic phase was concentrated to a residual volume of about 2 times (relative to 2.0V of cortisone acetate), purified water (10.0V) was added for crystallization, filtration, and drying to obtain intermediate 1 with an HPLC purity of 95% and a molar yield of 90%.

[0068] (2) 2-methyltetrahydrofuran (15.0 V) was added to the reaction flask, followed by the addition of intermediate 1 (1.0 eq), palladium carbon (0.09 w / w) and triethylamine (1.0 V), followed by nitrogen replacement 3 times and hydrogen replacement 3 times. The reaction was carried out at a temperature of 40 to 50° C. During the reaction, the progress of the reaction was detected by thin layer chromatography (TLC). After the reaction was complete, the mixture was filtered, and the filter cake was rinsed with an appropriate amount of 2-methyltetrahydrofuran. The organic phase was concentrated until there was no fraction, and acetone (6.0 V) was added for recrystallization, filtration and drying to obtain intermediate 2 with an HPLC purity of 95% and a molar yield of 63%.

[0069] (3) Under nitrogen protection, chloroform (10.0 V) was added to the reaction flask, and intermediate 2 (1.0 eq) was added. The mixture was stirred and cooled to 0-10° C. trimethylsilyl chloride (7.0 eq) and copper iodide (0.3 eq) were added in sequence. After the addition, the mixture was reacted at 0-10° C. The progress of the reaction was monitored by thin layer chromatography (TLC). After the reaction was complete, saturated sodium thiosulfate solution was added to terminate the reaction. The organic phase was concentrated to no fraction, and ethyl acetate (5.0 V) was added for recrystallization, filtration, and drying to obtain intermediate 3 with an HPLC purity of 93% and a molar yield of 78%.

[0070] (4) Under nitrogen protection, methyl tert-butyl ether (15.0 V) was added to the reaction bottle, and intermediate 3 (1.0 eq) was added. The mixture was stirred and cooled to 0-10° C., and diisopinocampheyl chloroborane (2.0 V) was added dropwise. After the addition, the reaction was carried out at a temperature of 0-10° C. The progress of the reaction was detected by thin layer chromatography (TLC). After the reaction was completed, methanol (0.5 V) was added to terminate the reaction. The organic phase was washed with 1 M hydrochloric acid solution, saturated sodium bicarbonate solution, and water, respectively, and acetonitrile (10.0 V) was added for recrystallization, filtration, and drying to obtain intermediate 4 with an HPLC purity of 91.52%, 2.71% hydrogenated isomer impurities, 3.53% reduced isomer impurities, 1.82% hydrogenated reduced isomer impurities, and a molar yield of 85%.

[0071] (5) Add triethyl orthoformate (10.0 V) to the reaction flask, and then add intermediate 4 (1.0 eq), 1,3-propylene glycol (2.0 eq), and N-bromosuccinimide (0.03 eq) in sequence. The reaction is carried out at a temperature of 20 to 30° C. During the reaction, the progress of the reaction is detected by thin layer chromatography (TLC). After the reaction is completed, add a mixed solvent of ethyl acetate (10.0 V) and saturated sodium bicarbonate solution (5.0 V). After separation, the organic phase is washed with water and concentrated to no fraction. Ethanol (15.0 V) is added for recrystallization, filtration, and drying to obtain intermediate 5 with an HPLC purity of 99.43% and a molar yield of 76%.

[0072] (6) Under nitrogen protection, cyclopentanone (15.0 V) was added to the reaction flask, followed by the addition of intermediate 5 (1.0 eq) and bisacetonitrile palladium chloride (0.1 eq), and the reaction was carried out at a temperature of 20 to 30° C. During the reaction, the progress of the reaction was detected by thin layer chromatography (TLC). After the reaction was completed, the organic phase was filtered and concentrated to a fraction-free state. Methanol (5.0 V) was added for crystallization, filtered, and dried to obtain alfaxalone with an HPLC purity of 99.74%, hydrogenated isomer impurities, reduced isomer impurities, and hydrogenated reduced isomer impurities all less than 0.05%, and a molar yield of 96%.

[0073] Example 5

[0074] (1) n-Butanol (10.0V) was added to a reaction flask, followed by the addition of cortisone acetate (1.0eq), followed by stirring and cooling to 0-10°C, and then sodium hydroxide (1.5eq) was added in batches. After the addition was completed, the reaction was carried out at a temperature of 0-10°C. During the reaction, the progress of the reaction was monitored by thin layer chromatography (TLC). After the reaction was completed, 1M hydrochloric acid solution was added to terminate the reaction. The organic phase was concentrated to a residual volume of about 1 times (relative to 1.0V of cortisone acetate), purified water (10.0V) was added for crystallization, filtration, and drying to obtain intermediate 1 with an HPLC purity of 98% and a molar yield of 88%.

[0075] (2) m-xylene (25.0 V) was added to the reaction flask, followed by the addition of intermediate 1 (1.0 eq), palladium carbon (0.08 w / w) and N,N-diisopropylethylamine (0.7 V), followed by nitrogen replacement 3 times and hydrogen replacement 3 times. The reaction was carried out at a temperature of 20 to 30 ° C. During the reaction, the progress of the reaction was detected by thin layer chromatography (TLC). After the reaction was complete, the filter was filtered, and the filter cake was rinsed with an appropriate amount of m-xylene. The organic phase was concentrated until there was no fraction, and isopropanol (8.0 V) was added for recrystallization, filtration, and drying to obtain intermediate 2 with an HPLC purity of 96% and a molar yield of 68%.

[0076] (3) Under nitrogen protection, 2-methyltetrahydrofuran (10.0 V) was added to the reaction bottle, and intermediate 2 (1.0 eq) was added. The mixture was stirred and cooled to 0-10° C., trimethylsilyl chloride (3.0 eq) and potassium iodide (0.1 eq) were added in sequence, and the reaction was carried out at a temperature of 0-10° C. The progress of the reaction was detected by thin layer chromatography (TLC). After the reaction was completed, saturated sodium thiosulfate solution was added to terminate the reaction. The organic phase was concentrated to no fraction, and methanol (5.0 V) was added for recrystallization, filtration, and drying to obtain intermediate 3 with an HPLC purity of 93% and a molar yield of 83%.

[0077] (4) Under nitrogen protection, chloroform (20.0V) was added to the reaction flask, and intermediate 3 (1.0eq) was added. The mixture was stirred and cooled to 0-10°C. Diisopine campheyl chloroborane (3.0V) was added dropwise. After the addition was completed, the reaction was carried out at a temperature of 0-10°C. The progress of the reaction was detected by thin layer chromatography (TLC). After the reaction was completed, methanol (0.5V) was added to terminate the reaction. The organic phase was washed with 1M hydrochloric acid solution, saturated sodium bicarbonate solution, and water, respectively, and acetone (10.0V) was added for recrystallization, filtration, and drying to obtain intermediate 4 with an HPLC purity of 92.23%, 2.61% hydrogenated isomer impurities, 3.32% reduced isomer impurities, 1.71% hydrogenated reduced isomer impurities, and a molar yield of 82%.

[0078] (5) Add triethyl orthoformate (10.0 V) to the reaction flask, and then add intermediate 4 (1.0 eq), 1,3-propylene glycol (4.0 eq), and N-bromosuccinimide (0.02 eq) in sequence. The reaction is carried out at a temperature of 20 to 30° C. During the reaction, the progress of the reaction is detected by thin layer chromatography (TLC). After the reaction is completed, add a mixed solvent of ethyl acetate (10.0 V) and saturated sodium bicarbonate solution (5.0 V). After separation, the organic phase is washed with water and concentrated to no fraction. Ethanol (15.0 V) is added for recrystallization, filtration, and drying to obtain intermediate 5 with an HPLC purity of 99.36% and a molar yield of 74%.

[0079] (6) Under nitrogen protection, cyclopentanone (15.0 V) was added to the reaction bottle, followed by the intermediate 5 (1.0 eq) and bisacetonitrile palladium chloride (0.1 eq), and the reaction was carried out at a temperature of 20 to 30° C. During the reaction, the progress of the reaction was detected by thin layer chromatography (TLC). After the reaction was completed, the organic phase was filtered and concentrated to no fraction. Acetonitrile (3.0 V) was added for crystallization, filtered, and dried to obtain alfaxalone with an HPLC purity of 99.72%, hydrogenated isomer impurities, reduced isomer impurities, and hydrogenated reduced isomer impurities all less than 0.05%, and a molar yield of 96%.

[0080] Comparative Example 1

[0081] Alfaxalone was prepared from 11-α-progesterone through four steps of hydrogenation, oxidation, reduction and silane protection.

[0082] (1) Add dichloromethane (15.7V) to a reaction flask, then add 11-α-progesterone (1.0eq), triethylamine (0.33V), and palladium / calcium carbonate (0.09w / w) in sequence, replace the atmosphere with nitrogen three times and hydrogen three times, react at 30±2°C, monitor the progress of the reaction by thin layer chromatography (TLC), filter after the reaction is complete, rinse the filter cake with an appropriate amount of dichloromethane, wash the organic phase with hydrochloric acid solution, sodium bicarbonate solution, and water, concentrate until there is no fraction, add methyl tert-butyl ether (5.0V) for slurry washing, and recrystallize with acetonitrile (12.5V) to obtain intermediate 2, with an HPLC purity of 95.30% and a molar yield of 56%.

[0083] (2) Dichloromethane (10.0 V) was added to the reaction flask, followed by the addition of intermediate 1 (1.0 eq) and tetrabutylammonium hydrogen sulfate (0.1 eq). After stirring and mixing, sodium hypochlorite pentahydrate (1.8 eq) was added in batches at a temperature of 20 to 24° C. The reaction progress was monitored by thin layer chromatography (TLC). After the reaction was complete, sodium thiosulfate solution was added to terminate the reaction. The organic phase was concentrated to no fraction, and then purified by column and washed with acetonitrile to obtain intermediate 2 with an HPLC purity of 92.50% and a molar yield of 45%.

[0084] (3) Isopropanol (45.0 V) was added to the reaction flask, followed by the intermediate 2 (1.0 eq) and potassium carbonate (0.6 eq). After nitrogen replacement three times, a ruthenium catalyst (RuCl[(S,S)-Tsdpen](p-isopropyltoluene), 0.023 eq) was added under nitrogen protection, and the reaction progress was monitored by thin layer chromatography (TLC). After the reaction was complete, activated carbon was added for decolorization and filtration, and the organic phase was concentrated until there was no fraction to obtain a crude product of alfaxalone with an HPLC purity of 81.30% and a molar yield of 80%.

[0085] (4) Add N,N-dimethylformamide (8.0V) to the reaction flask, stir and cool to -10 to -5°C, then add crude alfaxalone (1.0eq) and imidazole (0.38eq) in sequence, and add tert-butyldimethylsilyl chloride (0.30eq) in batches within 2 to 3 hours. After the addition, stir and heat to 2 to 8°C and continue stirring for 1.5 hours. Add cold water (23.5V) and filter. The obtained solid is dried to constant weight, and then purified by column and crystallized from isopropanol / purified water to obtain alfaxalone with HPLC purity of 95.50%, hydrogenated isomer impurity of 0.93%, reduced isomer impurity of 1.01%, hydrogenated reduced isomer impurity of 1.35%, and molar yield of 55%.

[0086] Table 1 Quality comparison of products from different synthesis methods

[0087]

[0088] In summary, the product yield of the synthetic route of the present invention is high, and the product HPLC purity is higher than that of comparative example 1. At the same time, intermediate 5 with high purity is obtained by crystallization through carbonyl protection, and alfaxalone with high purity is obtained by deprotection under mild conditions.

Claims

1. A method for synthesizing alfaxalone, characterized in that, The alfaxalone is prepared from cortisone acetate as a starting material through hydrolysis, hydrogenation, hydroxyl removal, carbonyl reduction, carbonyl protection, and carbonyl deprotection reactions.

2. a kind of synthetic method of alfaxalone according to claim 1, specific route is:

3. A method for synthesizing alfaxalone according to claim 1, wherein the specific synthesis steps are as follows: (1) Hydrolysis reaction: cortisone acetate is added to the reaction solvent, sodium hydroxide is added at a certain temperature to react, and the reaction progress is monitored by TLC. After the reaction is complete, hydrochloric acid solution is added to terminate the reaction. The organic phase is concentrated, crystallized by adding water, filtered, and dried to obtain intermediate 1; (2) Hydrogenation reaction: Intermediate 1, palladium carbon and amines are added to a reaction solvent and hydrogenated at normal pressure at a certain temperature. The reaction progress is monitored by TLC. After the reaction is complete, the organic phase is filtered, concentrated, recrystallized and dried to obtain Intermediate 2; (3) Dehydroxylation reaction: intermediate 2 is added to a reaction solvent, trimethylsilyl chloride and iodide salt are added in sequence at a certain temperature to react, and the reaction progress is monitored by TLC. After the reaction is complete, saturated sodium thiosulfate solution is added to terminate the reaction. The organic phase is concentrated, recrystallized, filtered, and dried to obtain intermediate 3; (4) Reduction reaction: intermediate 3 is added to a reaction solvent, diisopinoceneyl chloroborane is added at a certain temperature to react, the reaction progress is monitored by TLC, methanol is added after the reaction is complete to terminate the reaction, the organic phase is washed with hydrochloric acid solution, saturated sodium bicarbonate solution, and water, and then concentrated, recrystallized, filtered, and dried to obtain intermediate 4; (5) Carbonyl protection reaction: Intermediate 4, 1,3-propylene glycol and N-bromosuccinimide were added to triethyl orthoformate and reacted at a certain temperature. The reaction progress was monitored by TLC. After the reaction was complete, saturated sodium bicarbonate solution and ethyl acetate were added. After separation, the organic phase was washed with water, concentrated, recrystallized, filtered and dried to obtain intermediate 5. (6) Carbonyl deprotection reaction: Intermediate 5 and bis(acetonitrile palladium chloride) were added to the reaction solvent, and the deprotection reaction was carried out at a certain temperature. The progress of the reaction was monitored by TLC. After the reaction was complete, the organic phase was filtered, concentrated, crystallized, filtered, and dried to obtain alfaxalone.

4. A method for synthesizing alfaxalone according to claim 3, characterized in that, The amount of sodium hydroxide added in step (1) is 1.1 to 1.5 times the molar amount of cortisone acetate; the reaction solvent is one or more of methanol, ethanol, n-propanol, isopropanol, n-butanol, sec-butanol, and tert-butanol; the volume of the reaction solvent added is 5 to 15 times the mass of cortisone acetate; and the reaction temperature is 0 to 10°C.

5. A method for synthesizing alfaxalone according to claim 3, characterized in that, The amount of palladium carbon added in step (2) is 0.03 to 0.10 times the mass of intermediate 1; the amine solvent is one or more of triethylamine, diethylamine, ethylenediamine, and N,N-diisopropylethylamine; the volume of the amine solvent added is 0.1 to 2.0 times the mass of intermediate 1; the reaction solvent is one or more of dichloromethane, chloroform, tetrahydrofuran, 2-methyltetrahydrofuran, toluene, o-xylene, p-xylene, and m-xylene; the volume of the reaction solvent added is 10 to 30 times the mass of intermediate 1; the reaction temperature is 20 to 50°C; the recrystallization solvent is one or more of acetone, acetonitrile, methanol, ethanol, and isopropanol; the volume of the recrystallization solvent added is 3 to 10 times the mass of intermediate 1.

6. A method for synthesizing alfaxalone according to claim 3, characterized in that, The amount of trimethylchlorosilane added in step (3) is 2.0 to 10.0 times the molar amount of intermediate 2; the iodide salt is one or more of sodium iodide, potassium iodide, copper iodide, zinc iodide, calcium iodide, and magnesium iodide, and the amount of iodide salt added is 0.1 to 0.5 times the molar amount of intermediate 2; the reaction solvent is one or more of dichloromethane, chloroform, tetrahydrofuran, 2-methyltetrahydrofuran, and acetonitrile; the added volume of the reaction solvent is 5 to 10 times the mass of intermediate 2; the reaction temperature is 0 to 10° C.; the recrystallization solvent is one or more of acetone, ethyl acetate, and methanol; the added volume of the recrystallization solvent is 3 to 10 times the mass of intermediate 2.

7. A method for synthesizing alfaxalone according to claim 3, characterized in that, The added volume of diisopinoceneyl chloroborane in step (4) is 2 to 6 times the mass of intermediate 3, the reaction solvent is one or more of dichloromethane, chloroform, tetrahydrofuran, 2-methyltetrahydrofuran, and methyl tert-butyl ether; the added volume of the reaction solvent is 5 to 20 times the mass of intermediate 3; the reaction temperature is 0 to 10°C; the recrystallization solvent is one or more of acetone, ethyl acetate, methanol, ethanol, and isopropanol; the added volume of the recrystallization solvent is 3 to 20 times the mass of intermediate 3.

8. A method for synthesizing alfaxalone according to claim 3, characterized in that, In step (5), the amount of 1,3-propylene glycol added is 2.0 to 5.0 times the molar amount of intermediate 4, the amount of N-bromosuccinimide added is 0.01 to 0.05 times the molar amount of intermediate 4, the volume of triethyl orthoformate added is 5 to 10 times the mass of intermediate 4, the reaction temperature is 20 to 30° C., the recrystallization solvent is selected from methanol, ethanol, and isopropanol, and the volume of the recrystallization solvent added is 3 to 20 times the mass of intermediate 4.

9. A method for synthesizing alfaxalone according to claim 3, characterized in that, In step (6), the amount of bisacetonitrile palladium chloride added is 0.05 to 0.1 times the molar amount of intermediate 5, the reaction solvent is one or more of acetone, butanone, cyclopentanone, and methyl isobutyl ketone, the volume of the reaction solvent added is 10 to 20 times the mass of intermediate 5, the reaction temperature is 20 to 30° C., the crystallization solvent is selected from methanol, ethanol, isopropanol, and acetonitrile, and the volume of the crystallization solvent added is 1 to 10 times the mass of intermediate 5.

10. Use of alfaxalone obtained by the method for synthesizing alfaxalone as claimed in claims 1 to 9 in the preparation of anesthetic preparations for humans and animals.